Filtered By:
Source: Circulation Journal
This page shows you your search results in order of relevance. This is page number 14.
Order by Relevance | Date
Total 475 results found since Jan 2013.
Association Between Atrial High-Rate Episodes and Ischemic/Major Bleeding Events in Patients With a Cardiac Implantable Electronic Device - A 10-Year, Single-Center Historical Cohort Study
CONCLUSIONS: Longer AHRE duration is associated with a high number of major bleeding and ischemic events. Monitoring these bleeding risks is mandatory when clinicians are considering anticoagulation therapy for such patients.PMID:33867407 | DOI:10.1253/circj.CJ-20-1269
Source: Circulation Journal - April 19, 2021 Category: Cardiology Authors: Hironori Ishiguchi Akihiko Shimizu Masahiro Ishikura Masaaki Yoshida Koji Imoto Kazuhiko Sonoyama Tetsuya Kawabata Takashi Sugamori Masaya Ogawa Tomoyuki Uchida Tsukasa Nakamura Takeshi Morimoto Yu Yasuda Kazuaki Tanabe Yasuhiro Yoshiga Takayuki Okamura S Source Type: research
Effects of Acute Coronary Syndrome and Stable Coronary Artery Disease on Bleeding and Ischemic Risk After Percutaneous Coronary Intervention
CONCLUSIONS: Bleeding risk after PCI depended on both ACS presentation and HBR, with a significant effect of ACS within 30 days.PMID:33907052 | DOI:10.1253/circj.CJ-21-0016
Source: Circulation Journal - April 28, 2021 Category: Cardiology Authors: Masahiro Natsuaki Takeshi Morimoto Hiroki Shiomi Kazushige Kadota Tomohisa Tada Yasuaki Takeji Yukiko Matsumura-Nakano Yusuke Yoshikawa Hirotoshi Watanabe Ko Yamamoto Kazuaki Imada Takenori Domei Kyohei Yamaji Kazuhisa Kaneda Ryoji Taniguchi Natsuhiko Eha Source Type: research
Optimal Management of Anticoagulation Therapy in Asian Patients With Atrial Fibrillation
Circ J. 2021 Jun 5. doi: 10.1253/circj.CJ-21-0399. Online ahead of print.ABSTRACTStroke prevention is the cornerstone of management of atrial fibrillation (AF), and non-vitamin K antagonist oral anticoagulants (NOACs) are commonly prescribed. Because routine monitoring of anticoagulant effects of NOACs is not necessary, appropriate dosing following the criteria of each NOACs defined in pivotal randomized trials is important. Real-world data demonstrate that underdosing NOACs is associated with a higher risk of ischemic stroke without a lower risk of major bleeding. Furthermore, renal function of AF patients should be asses...
Source: Circulation Journal - June 7, 2021 Category: Cardiology Authors: Wen-Han Cheng Yi-Hsin Chan Jo-Nan Liao Ling Kuo Shih-Ann Chen Tze-Fan Chao Source Type: research
One-Year Outcome After Percutaneous Coronary Intervention for Acute Coronary Syndrome - An Analysis of 20,042 Patients From a Japanese Nationwide Registry
CONCLUSIONS: The results from our ACS hospital survivor PCI database suggest the need to improve care for the acute myocardial infarction population to lessen the burden of 30-day mortality due to ACS, heart failure, and sudden cardiac death, as well as 1-year ischemic stroke and heart failure events.PMID:34162778 | DOI:10.1253/circj.CJ-21-0098
Source: Circulation Journal - June 24, 2021 Category: Cardiology Authors: Mitsuaki Sawano Shun Kohsaka Hideki Ishii Yohei Numasawa Kyohei Yamaji Taku Inohara Tetsuya Amano Yuji Ikari Masato Nakamura Source Type: research
